Announcements and Notices - [Inside Information / Other - Trading Update]

TOT Biopharm International Company Limited operates biopharmaceutical company. The Company focuses on development and commercialisation of tumor drugs and therapies. TOT Biopharm International serves clients in China.

Certain Unaudited Financial Information
For The Nine Months Ended 30 September 2024

Notification Letter And Request Form For Non-Registered Shareholders

Notification Letter And Request Form For Registered Shareholders

Financial Statements/ESG Information - [Interim/Half-Year Report]

Interim Report 2024

Announcements and Notices - [Interim Results]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

TOT Biopharm International (1875 HK)

Certain Unaudited Financial Information For The Nine Months Ended 30 September 2024

Notification Letter And Request Form For Non-Registered Shareholders

Notification Letter And Request Form For Registered Shareholders

Interim Report 2024

Interim Results Announcement For The Six Months Ended 30 June 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)